trending Market Intelligence /marketintelligence/en/news-insights/trending/xtnjheug3i-ktderrpqrfw2 content esgSubNav
In This List

WuXi Biologics to build manufacturing facility in northern China

Case Study

Identifying PPE Suppliers During the Pandemic

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Video

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Blog

Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective


WuXi Biologics to build manufacturing facility in northern China

WuXi Biologics (Cayman) Inc. said it will build an integrated biologics facility in Shijiazhuang, the capital of China's Hebei province.

Biologics centers develop and manufacture biologic medical products using living microorganisms, plants or animal cells.

WuXi Biologics said the initial phase of the center is expected to be operational in 2020.

China-based WuXi Biologics is a provider of discovery, research, development and manufacturing of biologics services.